| Date Field | Doc. No. | Description (Pages) |
|---|
| Oct 26, 2015 | 1 | Main Document (23) |
| Oct 26, 2015 | 1 | Exhibit A - US Patent (12) |
| Oct 26, 2015 | 2 | Exhibit B - US Patent (17) |
| Oct 26, 2015 | 3 | Exhibit C - US Patent (11) |
| Oct 26, 2015 | 2 | Corporate Disclosure Statement (2) |
| Oct 26, 2015 | 4 | Supplemental Information for Patent Cases Involving a New Drug Application (NDA (1) |
| Oct 26, 2015 | 5 | Civil Cover Sheet (2) |
| Oct 26, 2015 | 1 | Main Document (23) |
| Oct 26, 2015 | 1 | Exhibit A - US Patent (12) |
| Oct 26, 2015 | 1 | Main Document (23) |
| Oct 26, 2015 | 2 | Exhibit B - US Patent (17) |
| Oct 26, 2015 | 1 | Exhibit A - US Patent (12) |
| Oct 26, 2015 | 1 | Main Document (23) |
| Oct 26, 2015 | 3 | Exhibit C - US Patent (11) |
| Oct 26, 2015 | 2 | Exhibit B - US Patent (17) |
| Oct 26, 2015 | 1 | Exhibit A - US Patent (12) |
| Oct 26, 2015 | 4 | Supplemental Information for Patent Cases Involving a New Drug Application (NDA (1) |
| Oct 26, 2015 | 3 | Exhibit C - US Patent (11) |
| Oct 26, 2015 | 2 | Exhibit B - US Patent (17) |
| Oct 26, 2015 | 5 | Civil Cover Sheet (2) |
| Oct 26, 2015 | 4 | Supplemental Information for Patent Cases Involving a New Drug Application (NDA (1) |
| Oct 26, 2015 | 3 | Exhibit C - US Patent (11) |
| Oct 26, 2015 | 5 | Civil Cover Sheet (2) |
| Oct 26, 2015 | 4 | Supplemental Information for Patent Cases Involving a New Drug Application (NDA (1) |
| Oct 26, 2015 | 2 | Corporate Disclosure Statement (2) |
| Oct 26, 2015 | 5 | Civil Cover Sheet (2) |
| Oct 26, 2015 | 1 | Main Document (23) |
| Oct 26, 2015 | 2 | Corporate Disclosure Statement (2) |
| Oct 26, 2015 | 1 | Exhibit A - US Patent (12) |
| Oct 26, 2015 | 2 | Corporate Disclosure Statement (2) |
| Oct 26, 2015 | 2 | Exhibit B - US Patent (17) |
| Oct 26, 2015 | 3 | Exhibit C - US Patent (11) |
| Oct 26, 2015 | 4 | Supplemental Information for Patent Cases Involving a New Drug Application (NDA (1) |
| Oct 26, 2015 | 5 | Civil Cover Sheet (2) |